Metabolic syndrome (consisting of increased waist circumference, hypertension, hypertriglyceridemia, low highdensity lipoprotein cholesterol [HDL-C], and hyperglycemia) became a medical diagnosis in adults in the late 1980s after publication of the concept that these cardiovascular (CV) risk factors may be linked together through a relation with insulin resistance. 1 The syndrome later became formally defined as the presence of any three of the above five components, 2 and it is widely accepted as an important predictor of CV disease and type 2 diabetes.
It is no secret that obesity has become a major universal health issue in children, that it is associated with significant metabolic dysfunction, and that it tracks into adulthood. Thus, it is not surprising that attempts have been made to develop a metabolic syndrome for children patterned on the adult syndrome. While the adult diagnosis is based on well-defined definitions for the five components comprising the syndrome, similar definitions are not available in children. As a consequence, arbitrary cutoff points, adapted from childhood standards, have been substituted. Using these criteria, it was estimated that the prevalence of the metabolic syndrome in adolescents was approximately 4%, with an increase to 29% in overweight adolescents. 3 However, the use of arbitrary definitions has led to controversy in pediatrics. The result is clearly shown in the paper by Costa et al. 4 published this month in the Journal, comparing three prevalence studies, each with its own separate independent definitions for diagnosing the metabolic syndrome. It is not clear why the different definitions were chosen, but the outcome is clear, i.e., three different definitions lead to three substantially different levels of prevalence for the childhood metabolic syndrome. It is understandable, as Costa et al. conclude, "disagreements regarding the prevalence of the disease in the pediatric population will be frequent".
There is general agreement that the risk factors comprising the metabolic syndrome tend to cluster together.
However, there are differences between adults and children. Emphasis on elevated CV risk factors in children is logical for pediatricians, who have always been at the forefront of preventive medicine. However, it is important to recognize that a focus on the metabolic syndrome rather than the individual risk factors may detract from the most effective approach to preventive care or therapy. First, the metabolic syndrome tracks poorly during childhood, 6,7 from childhood to young adulthood, 8 and to a greater degree in children in the higher risk categories. 9 As a consequence, major advisory bodies have raised questions about its usefulness in children. 10 The lack of tracking may be explained by longitudinal studies showing significant changes in levels of blood pressure, triglycerides and HDL-C during the transition from childhood to young adulthood. 11 of children with the metabolic syndrome at mean age 13
had the syndrome at mean age 22, they had significantly higher levels of BMI, waist circumference, percent body fat, and triglycerides and significantly lower levels of HDL-C, compared to individuals without the syndrome at age 13. 8 In an attempt to design a more reliable method than the metabolic syndrome for evaluating degrees of CV risk in children, we developed a metabolic factor cluster score by taking the average of the standardized deviates of the five metabolic syndrome criteria. The results were striking, with the cluster score at age 22 approximately eight times higher in the individuals with metabolic syndrome at age 13 than the non-metabolic syndrome group. In addition, there was a strong tracking effect for the cluster score (r = 0.51, p < 0.0001), indicating that relative rank of the cluster score at age 13 predicted its rank at age 22. These However, despite the combination of fasting glucose and insulin, HOMA is not an improvement over fasting insulin alone, with a correlation of r = 0.99 in children 14 and an equally high correlation in adults. Moreover, it is a poor estimate of insulin resistance in children, particularly in thin children. 14 It is not surprising that including HOMA instead of fasting glucose in the metabolic syndrome would significantly increase prevalence. This is most likely related to the confounding effect of fatness on insulin levels, as evidenced by the high correlation between fasting insulin and BMI in children 15 and the influence of obesity on insulin hypersecretion independent from obesity-related insulin resistance. 16 The relation between insulin resistance and the metabolic syndrome (or clustering of CV risk factors) has long been attractive as an etiologic unifying concept. 17 However, despite the significant relation between BMI and insulin resistance, studies in adults and children have shown that not all obese individuals are insulin resistant. Using data from a cohort of obese adults, the highest levels of insulin resistance were associated with the highest levels of blood pressure, plasma glucose and lipids. 18 Our studies have shown 1) in a cohort of 300 15 year olds significantly higher levels of CV risk factors are found in heavy-insulin resistant adolescents than heavy-insulin sensitive adolescents 19 ;
and 2) levels of insulin resistance at age 13 predict levels of blood pressure, triglycerides and a cluster score at age 19. 20 Thus, it appears that insulin resistance has a relevant, but undefined, role in early CV risk development. elevated CV risk has a significant relation to insulin resistance, but currently there are no simple and effective methods for measuring it; 3) obese children should be screened for elevated CV risk factors, with an emphasis on identifying abnormal factors as opposed to relying on the metabolic syndrome to determine degree of risk.
